Antiatherogenic effects of angiotensin receptor antagonism in mild renal dysfunction

Eisuke Suganuma, Yiqin Zuo, Nobuhiko Ayabe, Ji Ma, Vladimir R. Babaev, MacRae F. Linton, Sergio Fazio, Iekuni Ichikawa, Agnes B. Fogo, Valentina Kon

Research output: Contribution to journalArticlepeer-review

32 Scopus citations


Angiotensin II (Ang II) increases atherosclerotic cardiovascular disease. Renal damage that is characterized by activation of Ang II markedly potentiates the risk for atherosclerosis, even in the setting of subtle renal impairment. Therefore, whether antagonism of Ang II actions can modify atherosclerosis in a model of mild renal impairment was examined. Apolipoprotein E-deficient spontaneously hyperlipidemic mice underwent uninephrectomy (UNx) or sham operation (sham) followed by treatment with Ang II receptor antagonist losartan or hydralazine for 12 wk. While UNx did not increase the serum creatinine levels, BP and lipids were higher in UNx mice than in age-matched sham controls with intact kidneys. UNx caused a dramatic increase in the extent and the number of atherosclerotic lesions together with greater macrophage-positive area and more disruption in the elastin component of the extracellular matrix versus sham. Ang II antagonism dramatically decreased the UNx-induced acceleration in atherosclerosis in association with decreased macrophage content, linked to decreased macrophage migration in vitro with losartan but not with hydralazine. Aortae of mice treated with Ang II antagonism had fewer elastin breaks together with less immunostaining for the powerful elastolytic enzyme cathepsin S. None of these benefits was observed in the hydralazine-treated mice despite equivalent reduction in BP. These findings support an important role for endogenous Ang II in accelerated atherosclerosis in renal dysfunction and offer a therapeutic intervention with particular benefit in this setting through mechanisms that include reduced vascular macrophage infiltration and preservation of the elastin component of extracellular matrix.

Original languageEnglish (US)
Pages (from-to)433-441
Number of pages9
JournalJournal of the American Society of Nephrology
Issue number2
StatePublished - Feb 2006
Externally publishedYes

ASJC Scopus subject areas

  • Nephrology


Dive into the research topics of 'Antiatherogenic effects of angiotensin receptor antagonism in mild renal dysfunction'. Together they form a unique fingerprint.

Cite this